MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine

Migraine Disorders Clinical Trial

Official title:

MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03157739
• Other study ID #: CIN001 MigraineManager
• Status: Completed
• Phase: N/A
• Start date: December 6, 2017
• Est. completion date: April 30, 2018

Study information

• Verified date: July 2019
• Source: Children's Hospital Medical Center, Cincinnati
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to develop, evaluate, and optimize "MigraineManager", the first web-based comprehensive self-management tool for adolescents with migraine, their parents, and clinicians.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: April 30, 2018
• Est. primary completion date: April 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 11 Years to 18 Years

Eligibility

Inclusion Criteria:

• Patient is diagnosed with migraines using current International Classification of Headache Disorders criteria (ICHD-3 beta) for migraine with or without aura

• Patient has headache frequency of 8+ per month

• Access to the internet whether public (e.g., library) or private (e.g., home, personal)

• English fluency for patient, caregiver, and clinician

Exclusion Criteria:

• Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review

• Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review

Related Conditions & MeSH terms

• Migraine Disorders

Intervention

Behavioral:
• MigraineManager: Individualized Self-Management Tool
Answers provided during the online assessment will result in certain intervention recommendations. Once assessments are completed, a treatment plan will be automatically generated for patient and parent guidance.

Locations

Country	Name	City	State
United States	Kevin Hommel	Cincinnati	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Children's Hospital Medical Center, Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Headache frequency	change in number of days with headache	15 months